Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses.

J Bone Miner Res · 2022 · PMC10092421 · PMID 36088628

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Similarly, the higher (marginally significant) prevalent VF rate at the time of treatment discontinuation in the Pbo Discontinuation group with X‐rays would predict a higher MVF risk in the Pbo group.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.